ACOTEC SCIEN.H. DL-00001

Research ACOTEC SCIEN.H. DL-00001 (7W3) on Bullrun: market cap EUR 280.28M, P/E 17.4. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker7W3
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryMedical Devices
• CurrencyEUR
• Market capEUR 280.28M
• P/E17.4
• Financial periodFY2025
• RevenueEUR 644.63M
• Revenue growth20.7%
• Net incomeEUR 119.18M
• Free cash flowEUR 69.12M
• Gross margin73.9%

Valuation Snapshot

latest market cap is EUR 280.28M; P/E is 17.4.

About ACOTEC SCIEN.H. DL-00001

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with a vascular interventional approach;

Frequently asked questions

What is ACOTEC SCIEN.H. DL-00001's market cap?

ACOTEC SCIEN.H. DL-00001's market capitalization is EUR 280.28M.

What is ACOTEC SCIEN.H. DL-00001's P/E ratio?

ACOTEC SCIEN.H. DL-00001's price-to-earnings (P/E) ratio is 17.4.

What does ACOTEC SCIEN.H. DL-00001 do?

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally.